Company page

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. (ticker: ABOS) is a public company based in the United States with a market capitalization of approximately $163.2 million. The company focuses on developing innovative therapies for Alzheimer's disease and related neurodegenerative disorders. Acumen aims to address significant unmet medical needs in the field of neurology through its research and development efforts.